Zoloft and Bydureon bcise drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zoloft (sertraline hydrochloride) and Bydureon bcise (exenatide). Common drug interactions include injection site extravasation among females and injection site haemorrhage among males.

The phase IV clinical study analyzes what interactions people have when they take Zoloft and Bydureon bcise. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Zoloft?

Zoloft has active ingredients of sertraline hydrochloride. It is often used in depression. eHealthMe is studying from 138,798 Zoloft users. Check the latest studies of Zoloft.

What is Bydureon bcise?

Bydureon bcise has active ingredients of exenatide. eHealthMe is studying from 13,812 Bydureon bcise users. Check the latest studies of Bydureon bcise.

On Aug, 06, 2026

22 people who take Zoloft and Bydureon bcise together, and have interactions are studied.

Zoloft and Bydureon bcise drug interactions.

What are the common drug interactions of Zoloft and Bydureon Bcise, by gender? *:

female:

Injection site extravasation (flow of (blood or lymph) from injection site)
Injection site pain
Blood glucose increased
Injection site haemorrhage (bleeding from injection site)
Injection site mass
Age-related macular degeneration
Abdominal pain
Arthralgia (joint pain)
Blood sodium increased
Blood urea nitrogen/creatinine ratio decreased

male:

Injection site haemorrhage (bleeding from injection site)
Weight decreased
Incision site haemorrhage (bleeding from incision site)
Injection site pain
Insomnia (sleeplessness)
Keloid scar (overgrown scars left from skin injuries)
Nodule (a growth of abnormal tissue)
Type 2 diabetes mellitus
Appendicitis perforated (perforated appendicitis is a condition in which an inflamed appendix bursts)
Blood glucose increased

What are the common drug interactions of Zoloft and Bydureon Bcise, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Injection site extravasation (flow of (blood or lymph) from injection site)

30-39:

n/a

40-49:

Blood glucose increased
Appendicitis perforated (perforated appendicitis is a condition in which an inflamed appendix bursts)
Cholecystitis chronic (long lasting infection of gallbladder)
Constipation
Diarrhoea
Glycosylated haemoglobin increased
Incision site haemorrhage (bleeding from incision site)
Keloid scar (overgrown scars left from skin injuries)
Weight decreased

50-59:

Injection site extravasation (flow of (blood or lymph) from injection site)

60+:

Injection site haemorrhage (bleeding from injection site)
Type 2 diabetes mellitus
Chest pain
Chronic kidney disease
Constipation
Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
Decreased appetite
Dizziness
Dry skin
Dyspnoea (difficult or laboured respiration)

What are the existing conditions these people have? *

Type 2 Diabetes: 16 people, 72.73%
Stress And Anxiety: 10 people, 45.45%
High Blood Cholesterol: 8 people, 36.36%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 4 people, 18.18%
Hypersensitivity: 4 people, 18.18%
High Blood Pressure: 3 people, 13.64%
Diabetes: 3 people, 13.64%
Glycosylated Haemoglobin Increased: 3 people, 13.64%
Gout (uric acid crystals building up in the body): 2 people, 9.09%
Blood Cholesterol Decreased: 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Zoloft and Bydureon bcise?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously